There are currently 21 COVID-19 positive inpatients at Mount Nittany Medical Center. This according to Officials who say those patients range from ages 31 to 86, with 118 COVID related admissions and an average daily census of 25 COVID positive inpatients so far this month.
By comparison, there was an average daily census of 18 COVID positive inpatients in March with 124 COVID related admissions. They say this months numbers are the highest they’ve seen since January, following the Holiday Season.
The National Institutes of Health says it’s testing a new, experimental drug in severely ill Coronavirus patients. The Phase 3 Clinical Trial includes patients hospitalized with life-threatening cases of COVID-19, including those with Acute Respiratory Failure. The trial will test the drug Zyesami and the antiviral Remdesivir — both alone and in combination. The drugs will be tested for their safety and efficacy in hospitalized COVID-19 patients experiencing Acute Respiratory Distress Syndrome.